Latest News about Fda
Recent news which mentions Fda
Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD
January 06, 2024
From Benzinga
Hemp Should Be Deemed Compliant Unless It Exceeds 1% Total THC, 1 Of 7 Objectives For New Farm Bill
January 04, 2024
From Benzinga
AMA's Reimbursement Codes For Psychedelic-Assisted Therapies Take Effect: Here's What To Expect
January 03, 2024
From Benzinga
Biden Considers Marijuana Rescheduling: Boon Or Bust For The Industry? Former Top FDA Official Weighs In
January 02, 2024
From Benzinga
Reckitt's Mead Johnson Initiates Massive Recall Of 675K Cans Of Hypoallergenic Baby Formula Over Bacteria Contamination Fears
January 01, 2024
From Benzinga
Kentucky's Promising Opioid Addiction Treatment Initiative Stalls As New AG Ousts Leading Advocate
December 29, 2023
Tickers
NEWS
From Benzinga
2023 Cannabis Year In Review: NORML's Top Ten Events In Marijuana Policy
December 28, 2023
Tickers
NEWS
From Benzinga
Fibromyalgia Care Breakthrough: DEA Green Lights Biotech Partnership Exploring Ketamine Implant Therapy
December 28, 2023
From Benzinga
Why Is Neurology Focused Cingulate Stock Trading Higher Today?
December 28, 2023
From Benzinga
Why Coherus BioSciences Stock Is Climbing Today
December 27, 2023
From Benzinga
FDA Slaps Clinical Hold On Iovance Biotherapeutics' Lung Cancer Study After Patient Death
December 27, 2023
From Benzinga
Coherus BioSciences Stock Is Soaring After-Hours - Here's Why
December 26, 2023
From Benzinga
Oncternal Therapeutics Reports Patient Death In Mid-Stage Blood Cancer Study Treated With Second Dose Level
December 26, 2023
From Benzinga
Full Approval For Amgen's Flagship Cancer Drug Lumakras Pushed For Around Four Years
December 26, 2023
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.